1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

ZEAKXAXFIRHBSN-WDYLLCCDSA-N

InChI Key

ZEAKXAXFIRHBSN-WDYLLCCDSA-N

IUPAC name

(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate

Preferred name

1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

Phosphatidylcholine(18:1n7/22:6n3)

ChEBI

CHEBI:84812

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Flow cytometry has a significant impact on the cellular metabolome (General LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• Ctrl_vs_Ab
• BSA_Control_vs_AA